3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
9
Breast Neoplasms
8
Lymphoma, Mantle-Cell
7
Leukemia, Myeloid, Acute
7
Leukemia
7
Congenital Abnormalities
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Myeloproliferative Disorders
6
Multiple Myeloma
6
Lymphoma, Follicular
6
Lymphoma, B-Cell, Marginal Zone
6
Lymphoma, Non-Hodgkin
5
Lymphoma, Large B-Cell, Diffuse
5
Burkitt Lymphoma
5
Waldenstrom Macroglobulinemia
4
Myelodysplastic Syndromes
4
Lymphoma, Large-Cell, Immunoblastic
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia, Myeloid, Chronic-Phase
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Sezary Syndrome
3
Mycosis Fungoides
3
Melanoma
3
Lymphoma, Large-Cell, Anaplastic
3
Lymphoma, Extranodal NK-T-Cell
3
Lymphoma
3
Lung Neoplasms
3
Leukemia, Myeloid, Accelerated Phase
3
Hodgkin Disease
3
Interventions
Sorafenib
42
Bevacizumab
26
Oxaliplatin
21
Radiosurgery
19
Gemcitabine
17
Fluorouracil
15
Hepatectomy
13
lenvatinib
12
Radiofrequency Ablation
11
Nivolumab
11
Cisplatin
11
Radiotherapy
10
Doxorubicin
10
Capecitabine
10
durvalumab
9
Leucovorin
9
Blood Specimen Collection
9
atezolizumab
8
Liver Transplantation
8
Everolimus
7
Electroporation
7
pembrolizumab
6
camrelizumab
6
Sunitinib
6
Immunohistochemistry
6
Cryosurgery
6
Carboplatin
6
tremelimumab
5
sintilimab
5
apatinib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Liver Neoplasms
×
In Situ Hybridization, Fluorescence
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled